Yale Cancer Center Researchers Show Receptor Structure Reveals New Targets for Cancer Treatments
November 25, 2021
November 25, 2021
NEW HAVEN, Connecticut, Nov. 25 (TNSJou) -- Yale School of Medicine issued the following news:
A molecule known as anaplastic lymphoma kinase (ALK) is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors. But for years much about this molecule -- its role in the body, which molecules interact with it, what it looks like -- has remained unknown, limiting efforts to target it for treatment.
Now, two studies led by Yale . . .
A molecule known as anaplastic lymphoma kinase (ALK) is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors. But for years much about this molecule -- its role in the body, which molecules interact with it, what it looks like -- has remained unknown, limiting efforts to target it for treatment.
Now, two studies led by Yale . . .